Inizia
alpha62539

LNTH right direction as business and the price could improve

Long
Lantheus Holdings, Inc. (NASDAQ:LNTH)  
alpha62539  
NASDAQ:LNTH   Lantheus Holdings, Inc.
Trend Analysis Chart Patterns Fundamental Analysis LNTH revenueup support tradeidea longidea bullishidea
3
2
trendanalysis chartpattern fundamental lnth revenueup support tradeidea longidea bullishidea
LNTH recently purchased cancer drugs license which are in the Phase 1 with FDA, that look promising. The company raised some cash through senior convertible notes. Quarterly revenue grew 134% YoY to $239.3mm, driven by strengths across the portfolio.
Management raised Q4 and FY22 guidance to the upside from the top-bottom lines. Last ER looks like: Lantheus Non-GAAP EPS of $0.99 beats by $0.16, revenue of $239.29M beats by $11.41M.
The stock price retraced to its long term support zone and could start move up towards 80$ area.
Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.